HP-NAP ameliorates OXA-induced atopic dermatitis symptoms in mice.
Conclusions & clinical relevance: Taken together, our results showed that HP-NAP possessed the potential to be a novel immunomodulatory candidate drug against AD.
PMID: 32762390 [PubMed - as supplied by publisher]
Source: Immunopharmacology and Immunotoxicology - Category: Allergy & Immunology Tags: Immunopharmacol Immunotoxicol Source Type: research